BOT · ASX

Botanix Pharmaceuticals Limited (ASX:BOT)

AU$0.14

 -0.015 (-9.375%)
ASX:Live
10/10/2025 04:19:29 PM
HALO Small HALO Ords HALO Consensus Value GROWTH AUS Big Candle +2
Consensus Score
/10
Recommend
Target Price
Deviation
Unlock Full Consensus Insights

BOT Overview

BOT Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Weak

GARP

Very Weak

MQV Small

Very Weak

Valuation

Value

Consensus

Momentum

Price

Neutral

Earnings

Weak

Growth

Earnings

Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About BOT

Telephone

Address

Description

Botanix Pharmaceuticals Ltd. is a dermatology company, which engages in the provision of business of researching and developing dermatology and antimicrobial products. It operates through the Australia and the United States geographical segments. The company was founded by Matthew Callahan, Roger New, and Glen Travers in 1984 and is headquartered in West Perth, Australia.

BOT Price Chart

Key Stats

Market Cap

AU$315.31M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.1 - 0.54

Trade Value (12mth)

AU$719,815.00

1 week

-3.03%

1 month

45.45%

YTD

-64.44%

1 year

-58.44%

All time high

163.33

Key Fundamentals

EPS 3 yr Growth

246.70%

EBITDA Margin

%

Operating Cashflow

-$79m

Free Cash Flow Return

-73.80%

ROIC

-81.20%

Interest Coverage

-15.00

Quick Ratio

2.90

Other Data

Shares on Issue (Fully Dilluted)

1861m

HALO Sector

Next Company Report Date

28-Aug-26

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.24

BOT Announcements

Latest Announcements

Date Announcements

09 October 25

Change of Director's Interest Notice - V. Ippolito

×

Change of Director's Interest Notice - V. Ippolito

08 October 25

Application for quotation of securities - BOT

×

Application for quotation of securities - BOT

29 September 25

Change in substantial holding

×

Change in substantial holding

08 September 25

Botanix to Present at HC Wainwright Investment Conference

×

Botanix to Present at HC Wainwright Investment Conference

05 September 25

Botanix Announces Korean Regulatory Approval of ECCLOCK

×

Botanix Announces Korean Regulatory Approval of ECCLOCK

03 September 25

Application for quotation of securities - BOT

×

Application for quotation of securities - BOT

03 September 25

Section 708A(5)(e) Notice

×

Section 708A(5)(e) Notice

29 August 25

2025 Annual General Meeting - Key Dates

×

2025 Annual General Meeting - Key Dates

29 August 25

Appendix 4E & Annual Report for the Year Ended 30 June 2025

×

Appendix 4E & Annual Report for the Year Ended 30 June 2025

29 August 25

Appendix 4G and Corporate Governance Statement

×

Appendix 4G and Corporate Governance Statement

25 August 25

Botanix Appoints Dr Patricia Walker to the Board

×

Botanix Appoints Dr Patricia Walker to the Board

25 August 25

Initial Director's Interest Notice - Dr Patricia Walker

×

Initial Director's Interest Notice - Dr Patricia Walker

22 August 25

Notification regarding unquoted securities - BOT

×

Notification regarding unquoted securities - BOT

12 August 25

Canaccord Genuity 45th Annual Growth Conference Presentation

×

Canaccord Genuity 45th Annual Growth Conference Presentation

01 August 25

Notification of cessation of securities - BOT

×

Notification of cessation of securities - BOT

31 July 25

Response to ASX Aware Letter

×

Response to ASX Aware Letter

28 July 25

June 2025 Quarterly Activities Report and Appendix 4C

×

June 2025 Quarterly Activities Report and Appendix 4C

24 July 25

Botanix Webinar - Monday 28 July - Registration Information

×

Botanix Webinar - Monday 28 July - Registration Information

09 July 25

Botanix Sofdra Launch Update Presentation - Correction

×

Botanix Sofdra Launch Update Presentation - Correction

08 July 25

Botanix Provides Sofdra Launch Update

×

Botanix Provides Sofdra Launch Update

08 July 25

Sofdra Launch Update Investor Webinar

×

Sofdra Launch Update Investor Webinar

04 July 25

Botanix Webinar Tuesday 8 July 2025 Registration Information

×

Botanix Webinar Tuesday 8 July 2025 Registration Information

30 June 25

Application for quotation of securities - BOT

×

Application for quotation of securities - BOT

30 June 25

Notification of cessation of securities - BOT

×

Notification of cessation of securities - BOT

27 June 25

Becoming a substantial holder

×

Becoming a substantial holder

BOT Fundamentals

Per Share Records

Historical data

Forecast data

AUD 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.01 -0.01 -0.05 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.01 -0.01 -0.05 Lock Lock Lock
     Growth % Lock Lock Lock Lock 41.5 -16.5 -408.7 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.01 -0.01 -0.03 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.01 -0.01 -0.04 Lock Lock Lock
     Growth % Lock Lock Lock Lock 56.1 9.4 -473.6 Lock Lock Lock
     Yield % Lock Lock Lock Lock -8.1 -1.6 -13.4 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.02 0.06 0.04 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.01 0.04 0.03 Lock Lock Lock
     Growth % Lock Lock Lock Lock 86.6 370.1 -38.1 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 1,154 1,502 1,845 Lock Lock Lock
Basic m Lock Lock Lock Lock 1,154 1,502 1,845 Lock Lock Lock

Financial Records

Historical data

Forecast data

AUD 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
Income Statement
Sales $m Lock Lock Lock Lock 1 1 6 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A 13.1 526.6 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 10 8 11 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock -3 -6 -71 Lock Lock Lock
     Growth % Lock Lock Lock Lock -2,022.6 -100.9 -1,067.5 Lock Lock Lock
     Margin % Lock Lock Lock Lock -332.9 -591.4 -1,101.9 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 433 691 1,202 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -13 -15 -81 Lock Lock Lock
     Growth % Lock Lock Lock Lock 19.7 -21.3 -424.4 Lock Lock Lock
     Margin % Lock Lock Lock Lock -1,386.4 -1,487.3 -1,244.6 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 0 0 2 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -13 -15 -83 Lock Lock Lock
     Growth % Lock Lock Lock Lock 19.7 -20.8 -436.5 Lock Lock Lock
     Margin % Lock Lock Lock Lock -1,398.5 -1,494.3 -1,279.5 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -13 -15 -86 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock -4 -1 0 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -9 -14 -86 Lock Lock Lock
     Growth % Lock Lock Lock Lock 30.5 -51.5 -522.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock -1,000.5 -1,340.6 -1,332.7 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -12 -8 -79 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 7 18 1 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock -7 -18 -1 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 22 95 65 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -12 -8 -79 Lock Lock Lock
     Growth % Lock Lock Lock Lock -8.0 31.8 -857.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock -13.2 -8.0 -12.2 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 10 79 65 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 25 112 129 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 0 0 23 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -10 -79 -33 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 2 4 48 Lock Lock Lock
Equity $m Lock Lock Lock Lock 23 109 81 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 23 109 104 Lock Lock Lock
     Growth % Lock Lock Lock Lock 181.5 373.8 -4.2 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -36.9 -12.3 -66.9 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -39.9 -12.8 -106.3 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -82.0 -23.5 -74.7 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -58.9 -21.1 -81.2 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -77.6 -12.3 -73.8 Lock Lock Lock

Ratios Records

Historical data

Forecast data

AUD 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
Leverage
Interest Cover X Lock Lock Lock Lock -155.2 -1,443.6 -15.0 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 0.8 5.2 0.4 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -44.7 -72.9 -40.4 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 7.4 22.2 4.0 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 5.7 21.9 2.9 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 73.3 95.7 65.2 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -640.5 -217.8 -315.3 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 2.9 0.7 2.4 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 1.3 3.3 5.3 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.1 0.0 0.1 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 152.0 263.7 136.8 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.0 0.0 0.1 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.0 0.0 0.1 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -1,401.5 -1,482.5 -1,333.2 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -51.6 -13.6 -66.9 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -36.9 -12.3 -66.9 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.1 1.0 1.6 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -39.9 -12.8 -106.3 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -39.9 -12.8 -106.3 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 285.3 111.1 68.6 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 125.6 489.3 154.5 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 410.9 600.5 223.1 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 272.7 144.1 20.2 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 138.2 456.3 202.9 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

3.73%

Value ($M)

12

Prior Change

N/A

7 Day Change

N/A

1 Month Change

-0.40%

3 Month Change

-0.10%

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

BOT Shortsell

Frequently Asked Questions

The current share price of Botanix Pharmaceuticals Limited (BOT:ASX) is AU$0.14.
The 52-week high share price for Botanix Pharmaceuticals Limited (BOT:ASX) is AU$0.54.
The 52-week low share price for Botanix Pharmaceuticals Limited (BOT:ASX)? is AU$0.10.
Botanix Pharmaceuticals Limited (BOT:ASX) does not pay a dividend.
Botanix Pharmaceuticals Limited (BOT:ASX) does not pay a dividend.
Botanix Pharmaceuticals Limited (BOT:ASX) has a franking level of 0.0%.
Botanix Pharmaceuticals Limited (BOT:ASX) is classified in the Healthcare.
The current P/E ratio for Botanix Pharmaceuticals Limited (BOT:ASX) is .
The current share price of Botanix Pharmaceuticals Limited (BOT:ASX) is AU$0.14.
The 52-week high share price for Botanix Pharmaceuticals Limited (BOT:ASX) is AU$0.54.
The 52-week low share price for Botanix Pharmaceuticals Limited (BOT:ASX)? is AU$0.10.
Botanix Pharmaceuticals Limited (BOT:ASX) does not pay a dividend.
Botanix Pharmaceuticals Limited (BOT:ASX) does not pay a dividend.
Botanix Pharmaceuticals Limited (BOT:ASX) has a franking level of 0.0%.
Botanix Pharmaceuticals Limited (BOT:ASX) is classified in the Healthcare.
The current P/E ratio for Botanix Pharmaceuticals Limited (BOT:ASX) is .